| Omega-3 fatty acids and blood pressure. | |
| | |
MedLine Citation:
|
PMID: 20196972 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
There is substantial evidence that omega-3 fatty acids reduce blood pressure, with a greater effect in hypertensive patients and those with high-normal blood pressure. The dose of omega-3 fatty acids required to achieve a blood pressure reduction is likely to be at least 3-4 g/day. However, the magnitude of the blood pressure change can be increased by salt restriction or when omega-3 fatty acids are incorporated into a weight reducing program. It is also highly plausible that increased omega-3 fatty acid consumption as part of a dietary change including increased consumption of fruits and vegetables, and moderation of salt intake, will confer significant cardiovascular benefit. |
| | |
Authors:
|
T A Mori |
Publication Detail:
|
Type: Journal Article Date: 2010-02-25 |
Journal Detail:
|
Title: Cellular and molecular biology (Noisy-le-Grand, France) Volume: 56 ISSN: 1165-158X ISO Abbreviation: Cell. Mol. Biol. (Noisy-le-grand) Publication Date: 2010 |
Date Detail:
|
Created Date: 2010-03-03 Completed Date: 2010-06-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9216789 Medline TA: Cell Mol Biol (Noisy-le-grand) Country: France |
Other Details:
|
Languages: eng Pagination: 83-92 Citation Subset: IM |
Affiliation:
|
School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia and the Cardiovascular Research Centre, Perth, Western Australia, Australia. trevor.mori@uwa.edu.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antihypertensive Agents / pharmacology* Blood Pressure / drug effects* Catecholamines / physiology Controlled Clinical Trials as Topic Endothelium / drug effects Fatty Acids, Omega-3 / pharmacology* Female Humans Meta-Analysis as Topic Population Surveillance Rats Vasodilation / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents; 0/Catecholamines; 0/Fatty Acids, Omega-3 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: OMEGA-3 FATTY ACIDS, INFLAMMATION AND ANGIOGENESIS: BASIC MECHANISMS BEHIND THE CARDIOPROTECTIVE EFF...
Next Document: OMEGA-3 FATTY ACIDS VS. CARDIAC DISEASE - THE CONTRIBUTION OF THE OMEGA-3 INDEX.